Compounds > cepharanthine
Page last updated: 2024-08-21

cepharanthine and Ovarian Neoplasms

cepharanthine has been researched along with Ovarian Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, CZ; Jiang, JH; Liu, YX; Ma, F; Peng, YM; Wang, QD; Wang, YF; Zhang, Y1
Ketchart, W; Kongsaden, C; Mutirangura, A; Payon, V; Wonganan, P1
Allen, C; De Souza, R; Huynh, L; Piquette-Miller, M; Zahedi, P1
Mircheva, J; Tsuruo, T1
Arai, M; Jobo, T; Kuramoto, H; Shimoda, T; Ushiki, N1

Other Studies

5 other study(ies) available for cepharanthine and Ovarian Neoplasms

ArticleYear
Cepharanthine hydrochloride reverses P‑glycoprotein-mediated multidrug resistance in human ovarian carcinoma A2780/Taxol cells by inhibiting the PI3K/Akt signaling pathway.
    Oncology reports, 2017, Volume: 38, Issue:4

    Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Carcinoma; Cell Line, Tumor; Chromones; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Morpholines; Oncogene Protein v-akt; Ovarian Neoplasms; Paclitaxel; Phosphatidylinositol 3-Kinases; Signal Transduction

2017
Mechanism of Cepharanthine Cytotoxicity in Human Ovarian Cancer Cells.
    Planta medica, 2019, Volume: 85, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Ovarian Neoplasms

2019
Combination drug delivery strategy for the treatment of multidrug resistant ovarian cancer.
    Molecular pharmaceutics, 2011, Feb-07, Volume: 8, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Cell Line, Tumor; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Mice; Mice, SCID; Multidrug Resistance-Associated Proteins; Ovarian Neoplasms; Taxoids

2011
Enhancement of adriamycin cytotoxicity in sensitive and resistant sublines of human tumor cells by calcium antagonists.
    Tumori, 1990, Oct-31, Volume: 76, Issue:5

    Topics: Alkaloids; Benzylisoquinolines; Calcium Channel Blockers; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Female; Humans; Ovarian Neoplasms; Tumor Cells, Cultured; Verapamil

1990
[Effects of cepharanthin on leukopenia and thrombocytopenia caused by CDDP-ACR-CPA therapy of ovarian cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:9

    Topics: Adult; Aged; Alkaloids; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Leukopenia; Middle Aged; Ovarian Neoplasms; Peptichemio; Thrombocytopenia

1988